Remoxipride

Also known as: Remoxiprida

Drug #2051

Remoxipride is substituted benzamide antipsycotic and a selective D2 receptor antagonist.

Primary Characteristics

Remoxipride is also known as Remoxiprida.

Molecular Weight: 371.3 · Solubility in Water: 74mg/l · Non-proprietary name: Remoxipride.

Distribution: Remoxipride has a plasma protein binding is 89-98%.

Elimination: plasma half-life is 4-7hours.

Remoxipride is primarily indicated in conditions like Schizophrenia.

Remoxipride is also indicated for secondary conditions like Psychosis.

Remoxipride is contraindicated in conditions like Hypersensitivity.

None recorded.

None recorded.

Remoxipride is known to cause more or less tolerable side effects which are usually transient. These include Sleep disturbancesX.